Article Text

Download PDFPDF
Consequences of JAG1 mutations
  1. B M Kamath1,
  2. L Bason3,
  3. D A Piccoli1,
  4. I D Krantz2,
  5. N B Spinner2
  1. 1Divisions of Gastroenterology and Nutrition, The Children’s Hospital of Philadelphia, The University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  2. 2Division of Human Genetics, The Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
  3. 3Division of Genetics, DuPont Hospital, Delaware, DE, USA
  1. Correspondence to:
 Dr N B Spinner
 PhD, Division of Human Genetics, 1002 Abramson Research Building, The Children’s Hospital of Philadelphia, 34th Street and Civic Center Blvd, Philadelphia, PA 19104, USA;


Background: Alagille syndrome (AGS) is a multi-system, autosomal dominant disorder with highly variable expressivity, caused by mutations within the Jagged1 (JAG1) gene.

Methods: We studied 53 mutation positive relatives of 34 AGS probands to ascertain the frequency of clinical findings in JAG1 mutation carriers.

Results: Eleven of 53 (21%) mutation positive relatives had clinical features that would have led to a diagnosis of AGS. Seventeen of the 53 (32%) relatives had mild features of AGS, revealed only after targeted evaluation following the diagnosis of a proband in their family. Twenty five of the 53 (47%) mutation positive relatives did not meet clinical criteria, and two of these individuals had no features consistent with AGS at all. The frequency of cardiac and liver disease was notably lower in the relatives than in the probands, characterising the milder end of the phenotypic spectrum. The characteristic facies of AGS was the feature with the highest penetrance, occuring almost universally in mutation positive probands and relatives.

Conclusions: This study has implications for genetic counselling of families with AGS and JAG1 mutations.

  • Alagille syndrome
  • SSCP, single strand conformational polymorphism

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • This study was supported by NIDDK (grant numbers 1 K0B DR02641-01 and 1 RO1 DK53104), NCRR (grant no. M01 RR08084), and the Fred and Suzanne Biesecker Center for Pediatric Liver Disease at the Children’s Hospital of Philadelphia.